medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2018, Número 4

<< Anterior Siguiente >>

Arch Neurocien 2018; 23 (4)


Utilidad de los test Artículo de revisión cognoscitivos breves para detectar la demencia en población mexicana

Romo-Galindo DA, Padilla-Moya E

Idioma: Español
Referencias bibliográficas: 62
Paginas: 26-34
Archivo PDF: 355.99 Kb.


RESUMEN

Los test cognoscitivos breves o de cribado (TCB) son instrumentos que se han utilizado para detectar a las personas con demencia, entre los más utilizados a nivel internacional son el Mini Mental State Examination (MMSE), el Montreal Cognitive Assessment (MoCA), el Seven Minute Screen Test (7MS) y el Memory Impairment Screen (MIS).El objetivo de esta revisión fue analizar la utilidad de los TCB para detectar la demencia en población mexicana, se realizó una búsqueda de artículos en bases de datos y sitios web (PubMed, EBSCO y Google Scholar). El MMSE ha sido el instrumento más utilizado en México para detectar la demencia en comparación con el MoCA y el MIS, no se encontraron estudios relevantes acerca del 7MT. Sin embargo, el MoCA ha sido más útil para detectar el DCL y la demencia en comparación con el MMSE y el MIS. Cada instrumento presenta limitaciones y aspectos a considerar cuando son administrados para detectar la demencia como la edad y la escolaridad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Roebuck-Spencer T, Glen T, Puente A, Denney R, Ruff R, Hostetter G, et al. Cognitive screening tests versus comprehensive neuropsychological test batteries: A national academy of neuropsychology education paper. Arch Clin Neuropsychol 2017; 32(4): 491-498.

  2. Olazarán J, Hoyos-Alonso M, Del Ser T, Barral A, Conde-Sala J, Bermejo-Pareja F, et al. Aplicación práctica de los test cognitivos breves. Neurol 2016; 31(3): 183-194.

  3. Acosta-Castillo G, Sosa- Ortiz A. Epidemiología de las demencias. Arch Neurocien 2016; 21(1):1-6.

  4. Organización Mundial de la Salud. Demencia, Nota descriptiva No. 362. 2017. Disponible en http://www.who.int/ mediacentre/factsheets/fs362/es/

  5. Organización Mundial de la Salud. Demencia, una prioridad de salud pública. 2013.

  6. Wortmann M. Dementia: a global health priority-highlights from an ADI and World Health Organization report. Alzheimers Res Ther 2012; 4(5): 40.

  7. Prince M. World Alzheimer report 2015: the global impact of dementia: an analysis of prevalence, incidence, cost and trends. Alzheimer's Disease International 2016.

  8. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri C. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 2013; 9(1): 63-75.

  9. Sosa A, Albanese E, Stephan B, Dewey M, Acosta D, Ferri C, et al. Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS Med 2012; 9(2). e1001170.

  10. Sosa-Ortiz A, Acosta-Castillo I, Prince M. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res 2012; 43(8): 600-608.

  11. Mejia-Arango S, Gutierrez L. Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the mexican health and aging study. J Aging Health 2011; 23(7): 1050-74.

  12. Alberca R, López-Pousa S. Enfermedad de Alzheimer y otras demencias. México: Panamericana; 2007.

  13. Fernández M, Gobartt A, Balañá M. Behavioural symptoms in patients with Alzheimer's disease and their association with cognitive impairment. BMC Neurol 2010; 10(87): 1-9.

  14. López-Pousa S, Vilalta-Franch J, Garre-Olmo J, Pons S, Cucurella M. Caracterización y prevalencia de los síntomas psicológicos y conductuales en pacientes con demencia. Rev Neurol 2007; 45(11): 683-688.

  15. Cullen B, O’neill B, Evans J, Coen R, Lawlor B. A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry 2007; 78(8): 790-799.

  16. Ismail Z, Rajji T, Shulman K. Brief cognitive screening instruments: an update. Int J Geriatr Psychiatry 2010; 25(2): 111-120.

  17. Slater H, Young J. A review of brief cognitive assessment tests. Rev Clin Gerontol 2013; 23(2):164-176.

  18. Olazarán J, Hoyos-Alonso M, Del Ser T, Barral A, Conde-Sala J, Bermejo-Pareja F, et al. Aplicación práctica de los test cognitivos breves. Neurol 2016; 31(3): 183-194.

  19. Folstein M, Folstein S, McHugh P. 'Mini-mental State': A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 1975; 12:189-198.

  20. Monroe T, Carter M. Using the Folstein Mini Mental State Exam (MMSE) to explore methodological issues in cognitive aging research. Eur J Ageing 2012; 9(3): 265-274.

  21. Mitchell A. The Mini-Mental State Examination (MMSE): an update on its diagnostic validity for cognitive disorders. In: Larner A, editors. Cognitive screening instruments. London; Springer 2013; 15-46.

  22. Steis M, Schrauf R. A review of translations and adaptations of the Mini-Mental State Examination in languages other than English and Spanish. Res Gerontol Nurs 2009; 2(3): 214-224.

  23. Espino D, Lichtenstein M, Palmer R, Hazuda H. Ethnic Differences in Mini-Mental State Examination (MMSE) Scores: Where You Live Makes a Difference. J Am Geriatric Soc 2001; 49(5): 538-548.

  24. Spering C, Hobson V, Lucas J, Menon C, Hall J, O’Bryant S. Diagnostic accuracy of the MMSE in detecting probable and possible Alzheimer's disease in ethnically diverse highly educated individuals: an analysis of the NACC database. J Gerontol A Biol Sci Medi Sci 2012; 67(8): 890-896.

  25. Blesa R, Pujol M, Aguilar M, Santacruz P, Bertran-Serra I, Hernández G, et al. Clinical validity of the ‘mini-mental state’ for Spanish speaking communities. Neuropsychol 2001; 39(11): 1150-1157.

  26. Han C, Jo S, Jo I, Kim E, Park M, Kang Y. An adaptation of the Korean mini-mental state examination (K-MMSE) in elderly Koreans: demographic influence and population-based norms (the AGE study). Arch Gerontol Geriatr 2008; 47(3): 302-310.

  27. Kim T, Jhoo J, Park J, Kim J, Ryu S, Moon S, et al. Korean version of mini mental status examination for dementia screening and its' short form. Psychiatry Invest 2010; 7(2):102-108.

  28. Kochhann R, Cerveira M, Godinho C, Camozzato A, Chaves M. Evaluation of Mini-Mental State Examination scores according to different age and education strata, and sex, in a large brazilian healthy sample. Dement Neuropsychol 2009; 3(2): 88-93.

  29. O’Bryant S, Humphreys J, Smith G, Ivnik R, Graff-Radford N, Petersen R, et al. Detecting dementia with the minimental state examination in highly educated individuals. Arch Neurol 2008; 65(7):963-967.

  30. Xu G, Meyer J, Huang Y, Du F, Chowdhury M, Quach M. Adapting Mini-Mental State Examination for dementia screening among illiterate or minimally educated elderly Chinese. Int J Geriatr Psychiatry 2003; 18(7): 609-616.

  31. Cossa M, Sala S, Musicco M, Spinnler H, Ubezio M. Comparison of two scoring systems of the Mini-Mental State Examination as a screening test for dementia. J Clin Epidemiol 1997; 50(8): 961-965.

  32. Nasreddine S, Phillips N, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53(4): 695-699.

  33. Llamas-Velasco S, Llorente-Ayuso L, Contador I, Bermejo-Pareja F. Versiones en español del Minimental State Examination (MMSE). Cuestiones para su uso en la práctica clínica. Rev Neurol 2015; 61: 363-71.

  34. Freitas S, Simões M, Alves L, Santana I. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 2013; 27(1): 37-43.

  35. Fujiwara Y, Suzuki H, Yasunaga M, Sugiyama M, Ijuin M, Sakuma N, et al. Brief screening tool for mild cognitive impairment in older Japanese: validation of the Japanese version of the Montreal cognitive assessment. Geriatr Gerontol Int 2010; 10(3): 225-232.

  36. Gil L, Ruiz de Sánchez C, Gil F, Romero S, Pretelt Burgos F. Validation of the Montreal cognitive assessment (MoCA) in Spanish as a screening tool for mild cognitive impairment and mild dementia in patients over 65 years old in Bogotá, Colombia. Int J Geriatric Psychiatry 2015; 30(6): 655-662.

  37. Bosco A, Spano G, Caffó A, Lopez A, Grattagliano I, Saracino G, et al. Italians do it worse. Montreal Cognitive Assessment (MoCA) optimal cut-off scores for people with probable Alzheimer’s disease and with probable cognitive impairment. Aging Clin Exp Res 2017; 29 (6): 1113–1120.

  38. Julayanont P, Nasreddine Z. S. Montreal Cognitive Assessment (MoCA): concept and clinical review. In: Larner A, editors. Cognitive screening instruments. London: Springer; 2013. p. 139-195.

  39. Ciesielska N, Sokolowski R, Mazur E, Podhorecka M, Polak-Szabela A, Kedziora-Kornatowska K. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol 2016; 50(5): 1039-1052.

  40. Dong Y, Lee W, Basri N, Collinson S, Merchant R, Venketasubramanian N, et al. The Montreal Cognitive Assessment is superior to the Mini–Mental State Examination in detecting patients at higher risk of dementia. Int Psychogeriatric 2012; 24(11): 1749-1755.

  41. Rossetti H, Lacritz L, Cullum C, Weiner M. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology 2011; 77(13): 1272-1275.g

  42. Zhou Y, Ortiz F, Nuñez C, Elashoff D, Woo E, Apostolova L, et al. Use of the MoCA in detecting early Alzheimer's disease in a spanish-speaking population with varied levels of education. Dement Geriatr Cogn Dis Extra 2015; 5(1): 85-95.

  43. Ojeda N, Pino R, Ibarretxe-Bilbao N, Schretlen D, Peña J. Test de evaluación cognitiva de Montreal: normalización y estandarización de la prueba en población española. Rev Neurol 2016; 63(11): 488-496.

  44. Delgado C, Araneda A, Behrens M. Validación del instrumento Montreal Cognitive Assessment en español en adultos mayores de 60 años. Neurol 2017; doi.org/10.1016/j.nrl.2017.01.013.

  45. Nasreddine Z, Phillips N, Chertkow H, Rossetti H, Lacritz L, Cullum M, et al. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurol 2012; 78(10): 765-766.

  46. Buschke H, Kuslansky G, Katz M, Stewart W, Sliwinski M, Eckholdt H, et al. Screening for dementia with the memory impairment screen. Neurol 1999; 52(2): 231-231.

  47. Pérez-Martínez D, Baztán J, González-Becerra M, Socorro A. Evaluación de la utilidad diagnóstica de una adaptación española del Memory Impairment Screen de Buschke para detectar demencia y deterioro cognitivo. Rev Neurol 2005; 40 (11); 644-648.

  48. Barrero-Hernández F, Vives-Montero F, Morales-Gordo B. Evaluación de la versión española del Memory Impairment Screen. Rev Neurol 2006; 43(1): 15-19.

  49. Böhm P, Pena-Casanova J, Gramunt N, Manero R, Terron C, Quinones-Ubeda S. Spanish version of the Memory Impairment Screen (MIS): normative data and discriminant validity. Neurol 2005; 20(8): 402-411.

  50. Modrego P, Gazulla J. The predictive value of the memory impairment screen in patients with subjective memory complaints: a prospective study. Prim Care Companion CNS Disord 2013; doi:10.4088/PCC.12m01435.

  51. Solomon P, Hirschoff A, Kelly B, Relin M, Brush M, DeVeaux R, et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer’s disease. Arch Neurol 1998; 55: 349-355.

  52. Henderson V. Detecting dementia in just 12 minutes: the seven minute screen. J Neurol Neurosurg Psychiatry 2004; 75(5): 666-667.

  53. Del Ser T, Sánchez-Sánchez F, de Yébenes M, Otero A, Munoz D. Validation of the seven-minute screen neurocognitive battery for the diagnosis of dementia in a Spanish population-based sample. Dement Geriatr Cogn Disord 2006; 22(5-6): 454-464.

  54. Del Ser Quijano T, Sánchez- Sánchez F, García de Yebenes M, Otero-Puime A, Zunzunegui M, Muñoz, D. Versión española del Test de los 7 Minutos. Datos normativos de una muestra poblacional de ancianos de más de 70 años. Neurol 2004; 19(7): 344-358.

  55. Ijuin M, Homma A, Mimura M, Kitamura S, Kawai Y, Imai Y, et al. Validation of the 7-Minute Screen for the detection of early-stage Alzheimer’s disease. Dement Geriatr Cogn Disord 2008; 25(3): 248-255.

  56. Skjerve A, Nordhus I, Engedal, K, Pallesen S, Brækhus A, Nygaard H. Seven minute screen performance in a normal elderly sample. Int J Geriatr Psychiatry 2007; 22(8): 764-769.

  57. Mokri H, Ávila-Funes J, Meillon C, Gutiérrez-Robledo L, Amieva H. Normative data for the mini-mental state examination, the free and cued selective reminding test and the Isaacs set test for an older adult Mexican population: the Coyoacán cohort study. Clin Neuropsychol 2013; 27(6): 1004-1018.

  58. Villaseñor-Cabrera T, Guàrdia-Olmos J, Jiménez-Maldonado M, Rizo-Curiel G, Peró-Cebollero M. Sensitivity and specificity of the Mini-Mental State Examination in the Mexican population. Qual Quant 2010; 44(6): 1105-1112.

  59. Beaman S, Beaman P, García-Peña C, Villa M, Heres J, Córdova A, et al. Validation of a modified version of the Mini- Mental State Examination (MMSE) in Spanish. Aging, Neuropsychol Cog 2004; 11(1): 1-11.

  60. Aguilar-Navarro S, Mimenza-Alvarado A, Palacios-García A, Samudio-Cruz A, Gutiérrez-Gutiérrez L, Ávila-Funes J. Validez y confiabilidad del MoCA (Montreal Cognitive Assessment) para el tamizaje del deterioro cognoscitivo en México. Rev Colomb Psiquiatr 2017; 7(4):237-243.

  61. Zhou Y, Ortiz F, Nuñez C, Elashoff D, Woo E, Apostolova L, et al. Use of the MoCA in detecting early Alzheimer's Disease in a spanish-speaking population with varied levels of education. Dement Geriatr Cogn Dis Extra 2015; 5(1): 85-95.

  62. Ortiz X, Gámez D, Salinas R. Validation of the Memory Impairment Screen (MIS) for dementia in the Mexican population. Rev Mex Invest Psic 2017;7(1): 7-15.




2020     |     www.medigraphic.com